The in vivo results showed that corilagin significantly reduced paw swelling and arthritis score and inhibited joint erosion and the infiltration of inflammatory cells; pro-inflammatory cytokines were also inhibited at the serum level (IL-6, TNF-α, IL-1β, and IL-17). Here, IL17A is linked to arthritic joint disease.